| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,177 |
9,423 |
$923K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,094 |
4,275 |
$613K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,431 |
1,107 |
$375K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,363 |
2,821 |
$193K |
| 80053 |
Comprehensive metabolic panel |
4,775 |
4,324 |
$143K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,106 |
4,521 |
$115K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,167 |
1,084 |
$62K |
| 36415 |
Collection of venous blood by venipuncture |
8,354 |
7,175 |
$57K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
253 |
243 |
$25K |
| J3490 |
Unclassified drugs |
2,059 |
975 |
$24K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
256 |
222 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
197 |
178 |
$15K |
| 80306 |
|
233 |
208 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
391 |
323 |
$13K |
| 83605 |
|
258 |
234 |
$12K |
| 84145 |
|
158 |
147 |
$12K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
234 |
222 |
$10K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
85 |
26 |
$8K |
| 84484 |
|
163 |
139 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
121 |
108 |
$7K |
| 86140 |
|
235 |
214 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
587 |
560 |
$6K |
| 83735 |
|
208 |
190 |
$5K |
| 81001 |
|
364 |
321 |
$4K |
| 73630 |
|
51 |
38 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
18 |
18 |
$3K |
| 83880 |
|
49 |
43 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
231 |
209 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
78 |
73 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
79 |
74 |
$2K |
| 85379 |
|
61 |
54 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
25 |
24 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
109 |
92 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
27 |
27 |
$1K |
| 87040 |
|
22 |
12 |
$1K |
| 0240U |
|
20 |
16 |
$987.27 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15 |
12 |
$853.87 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
66 |
66 |
$774.54 |
| 81003 |
|
62 |
49 |
$638.12 |
| J2704 |
Injection, propofol, 10 mg |
56 |
50 |
$608.88 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28 |
27 |
$515.03 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$439.88 |
| 80061 |
Lipid panel |
25 |
25 |
$350.32 |
| 83690 |
|
12 |
12 |
$312.16 |
| 82077 |
|
15 |
12 |
$275.97 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12 |
12 |
$245.43 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
13 |
$189.58 |
| 85652 |
|
15 |
12 |
$156.87 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
45 |
42 |
$149.53 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
13 |
$123.01 |